Evidence map›Paper›PMID 24123783›Full record

ArticleAngewandte Chemie (International ed. in English)2013

PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles.

Jinbin Liu, Mengxiao Yu, Xuhui Ning, Chen Zhou, Shengyang Yang, Jie Zheng

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it, 267 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Atomically-precise AuJournal of nanobiotechnology · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Targeted nanotherapy for kidney diseases: a comprehensive review.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Review
  17. Ligand engineering of AuChemical science · 2023
    Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jinbin LiuDepartment of Chemistry, The University of Texas at Dallas, 800 W. Campbell Rd. Richardson, Texas, 75080 (USA) http://www.utdallas.edu/∼jiezheng.
Mengxiao Yu
Xuhui Ning
Chen Zhou
Shengyang Yang
Jie Zheng
The University of Texas at Dallas · US

Funding

Develop a Dual Functional Nanoprobe for Integration of Fluorescence microscopy wiR21EB011762 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI ZHENG, JIE · 2011 to 2012
$402k
Cell-and Nucleus-Permeable Luminescent Gold NanoparticlesR21EB009853 · NIBIB · UNIVERSITY OF TEXAS DALLAS · PI ZHENG, JIE · 2009 to 2010
$394k
NIBIB NIH HHS R21 EB009853NIBIB NIH HHS R21EB009853NIBIB NIH HHS R21 EB011762
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GoldLuminescent AgentsNanoparticlesAnimalsCell Line, TumorHumansIonsKidneyMiceMice, NudeNeoplasmsOptical ImagingPolyethylene GlycolsGoldIonsLuminescent AgentsPolyethylene GlycolsnanoparticlesPEGylationrenal clearancesurface chemistrytumor targeting

Identifiers

PMID24123783
PMCPMC4127427
OpenAlexW2133671258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.